Nuvation Bio Inc (NUVB)
Healthcare
Biotechnology
6.20 $
-2.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Nuvation Bio Inc (NUVB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -173 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -0.6 | -24 | -37 | -68 | -96 | -68 | -130 | -173 | |
| 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.7 | 1.7 | |
| – | – | 2.2 | 9.3 | 16 | 20 | 32 | 36 | |
| 7.6 | 7.6 | 2.9 | 14 | 7.4 | – | – | – | |
| 0.3 | -0.5 | 2.1 | 4.8 | -3.4 | 0.5 | -13 | -12 | |
| 0.7 | 0.7 | 0.1 | 0.3 | 0.4 | 0.1 | 0.2 | 0.4 | |
| -116 | -116 | -70 | -455 | 63 | 8.9 | 123 | 100 | |
| – | – | 136 | 0.8 | 0.9 | – | – | – | |
| 0.8 | 14 | – | – | – | 0.0 | -4.6 | 48 | |
| 0.8 | 144 | 133 | 626 | 1.3 | 0.6 | 0.3 | 203 | |
| 0.2 | 3.3 | 26 | 103 | -31 | -58 | -6.9 | 128 | |
| -0.6 | -25 | -37 | -68 | -96 | -68 | -131 | -174 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.